Prolia Drug Interactions

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage Patient Counseling Information MIMS Class ATC Classification Thai FDA Category Presentation/Packing

The information highlighted (if any) are the most recent updates for this brand.

Full Prescribing Info

Drug Interactions

PROLIA (60 mg subcutaneously) did not affect the pharmacokinetics of midazolam, which is metabolised by cytochrome P450 3A4 (CYP3A4), indicating that it should not affect the pharmacokinetics of drugs metabolised by this enzyme (see PHARMACOLOGY: Pharmacokinetics under Actions). Concomitant use with immunosuppressive agents may increase the risk of serious infections. Risks and benefits should be assessed to guide use of PROLIA in patients receiving immunosuppressive agents.

Prolia Drug Interactions

denosumab

Manufacturer:

Amgen

Distributor:

Zuellig Pharma